Campus Sant' Ana, Polo de Investigação, Nova Medical School, Edifício Amarelo, Rua do Instituto Bacteriológico no. 5, Universidade Nova de Lisboa, 1150-082, Lisbon, Portugal.
Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
Arch Osteoporos. 2018 Mar 7;13(1):22. doi: 10.1007/s11657-018-0430-z.
Using a large population database, we showed that fragility fractures were highly prevalent in senior women and were associated with significant physical disability. However, treatment rates were low because osteoporosis treatment was not prescribed or not agreed to by the majority of women with prevalent fragility fractures.
The purpose of the study is to estimate prevalence of fragility fractures (FF), risk factors, and treatment rates in senior women and to assess impact of FF on physical function and quality of life.
Women aged 65 years and older from the EpiReumaPt study (2011-2013) were evaluated. Rheumatologists collected data regarding FF, clinical risk factors for fractures, and osteoporosis (OP) treatment. Health-related quality of life (EQ5D) and physical function (HAQ) were analyzed. Peripheral dual-energy X-ray absorptiometry was performed. FF was defined as any self-reported low-impact fracture that occurred after 40 years of age. Prevalence estimates of FF were calculated.
Among 3877 subjects evaluated in EpiReumaPt, 884 were senior women. The estimated prevalence of FF was 20.7%. Lower leg was the most frequent fracture site reported (37.8%) followed by wrist (18.6%). Only 7.1% of the senior women reporting a prevalent FF were under treatment for OP, and 13.9% never had treatment. OP treatment was not prescribed in 47.7% of FF women, and 23.4% refused treatment. Age (OR = 2.46, 95% CI 1.11-5.47), obesity (OR = 2.05, 95% CI 1.14-3.70), and low wrist BMD (OR = 2.29; 95% CI 1.20, 4.35; p = 0.012) were positively associated with prevalent FF. A significantly higher proportion of women in the lowest quintile of wrist bone mineral density reported FF (OR = 2.29, 95% CI 1.20-4.35). FF were associated with greater physical disability (β = 0.33, 95% CI 0.13-0.51) independent of other comorbidities.
FF was frequently reported among senior women as an important cause of physical disability. However, the prevalence of OP treatment was low, which constitutes a public health problem in this vulnerable group.
本研究旨在评估老年女性脆性骨折(FF)的患病率、危险因素和治疗率,并评估 FF 对身体功能和生活质量的影响。
研究纳入了 2011-2013 年 EpiReumaPt 研究中的年龄≥65 岁的女性。风湿病学家收集了 FF、骨折临床危险因素和骨质疏松症(OP)治疗的数据。分析了健康相关生活质量(EQ5D)和身体功能(HAQ)。进行了外周双能 X 线吸收法检查。FF 定义为 40 岁后发生的任何自报告低能量骨折。计算 FF 的患病率估计值。
在 EpiReumaPt 中评估的 3877 名受试者中,有 884 名为老年女性。FF 的估计患病率为 20.7%。报告的最常见骨折部位是小腿(37.8%),其次是手腕(18.6%)。仅 7.1%的报告有 FF 的老年女性接受 OP 治疗,13.9%的女性从未接受过治疗。OP 治疗未被开具给 47.7%的 FF 女性,23.4%的女性拒绝治疗。年龄(OR=2.46,95%CI 1.11-5.47)、肥胖(OR=2.05,95%CI 1.14-3.70)和低手腕骨密度(OR=2.29;95%CI 1.20-4.35;p=0.012)与 FF 呈正相关。手腕骨密度最低五分位的女性报告 FF 的比例显著更高(OR=2.29,95%CI 1.20-4.35)。FF 与更大的身体残疾有关(β=0.33,95%CI 0.13-0.51),独立于其他合并症。
FF 在老年女性中经常报告,是身体残疾的重要原因。然而,OP 治疗的患病率较低,这在这个弱势群体中构成了一个公共卫生问题。